Literature DB >> 10223331

The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response.

P M Kloetzel1, A Soza, R Stohwasser.   

Abstract

The generation of antigenic peptides bound and presented to the immune system by MHC class I molecules predominantly depends on the function of the proteasome system. Stimulation of cells with interferon gamma induces the incorporation of three active site bearing beta-subunits into the 20S proteasome and the formation of the PA28 proteasome modulator complex. PA28 alters the cleavage properties of the proteasome and enhances MHC class I antigen presentation. Thus, by cytokine induced change of the proteasome system cells may alter the proteolytic properties of the 20S proteasome and may render an organism more flexible in its peptide generation capacity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10223331     DOI: 10.1515/BC.1999.040

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  15 in total

1.  High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12.

Authors:  R H Duerr; M M Barmada; L Zhang; R Pfützer; D E Weeks
Journal:  Am J Hum Genet       Date:  2000-04-03       Impact factor: 11.025

2.  Age-dependent inhibition of proteasome chymotrypsin-like activity in the retina.

Authors:  Rebecca J Kapphahn; Erin J Bigelow; Deborah A Ferrington
Journal:  Exp Eye Res       Date:  2007-01-25       Impact factor: 3.467

3.  Enhancement of proteasome function by PA28α overexpression protects against oxidative stress.

Authors:  Jie Li; Saul R Powell; Xuejun Wang
Journal:  FASEB J       Date:  2010-11-23       Impact factor: 5.191

Review 4.  The ubiquitin-proteasome system in myocardial ischaemia and preconditioning.

Authors:  Saul R Powell; Andras Divald
Journal:  Cardiovasc Res       Date:  2009-09-30       Impact factor: 10.787

5.  Degradation of retinoid X receptor alpha by TPA through proteasome pathway in gastric cancer cells.

Authors:  Xiao-Feng Ye; Su Liu; Qiao Wu; Xiao-Feng Lin; Bing Zhang; Jia-Fa Wu; Ming-Qing Zhang; Wen-Jin Su
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 6.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

7.  MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: involvement of nuclear factor-kappaB and activator protein-1.

Authors:  Pablo C Ortiz-Lazareno; Georgina Hernandez-Flores; Jorge R Dominguez-Rodriguez; Jose M Lerma-Diaz; Luis F Jave-Suarez; Adriana Aguilar-Lemarroy; Piedad C Gomez-Contreras; Daniel Scott-Algara; Alejandro Bravo-Cuellar
Journal:  Immunology       Date:  2008-02-20       Impact factor: 7.397

8.  Transformation of the proteasome with age-related macular degeneration.

Authors:  Cheryl M Ethen; Stacy A Hussong; Cavan Reilly; Xiao Feng; Timothy W Olsen; Deborah A Ferrington
Journal:  FEBS Lett       Date:  2007-02-02       Impact factor: 4.124

Review 9.  The ubiquitin-proteasome system in retinal health and disease.

Authors:  Laura Campello; Julián Esteve-Rudd; Nicolás Cuenca; José Martín-Nieto
Journal:  Mol Neurobiol       Date:  2013-01-22       Impact factor: 5.590

10.  Corneal wound healing is compromised by immunoproteasome deficiency.

Authors:  Deborah A Ferrington; Heidi Roehrich; Angela A Chang; Craig W Huang; Marcela Maldonado; Wendy Bratten; Abrar A Rageh; Neal D Heuss; Dale S Gregerson; Elizabeth F Nelson; Ching Yuan
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.